Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Pak J Pharm Sci ; 37(1(Special)): 199-203, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38747270

RESUMEN

This study investigates the combined effect of vitamin C and chromium on BMI, lipid profile, LFTs and HbA1c of Diabetes Mellitus type 2 patients. This is randomized controlled trial study. For this study a total of 60 patients (n=28 female, n=32 male) Diabetes Mellitus type 2 patients were selected. They were divided into treatment group (vitamin C (500mg) Chromium (200µg) and control group (placebo) comprising thirty patients per group. Mean age in control group and treatment group is 33± 5.729 and 33±7.017 respectively. Statistical analysis showed significant results of lipid profile; total cholesterol (mg/dl) 198±66.1 P=0.008, High-Density Lipoprotein 38±7.5, P<0.001, Low Density Lipoprotein (LDL) (mg/dl) 105.1±22.4, P=0.002 and Triglycerides 191±64.3, P=0.02 are respectively. Levels of serum ALT (u/l) (34.7±9.1, P<0.001) and AST (u/l) (31.6 ±8.6, P<0.001) were significantly lower as compared to control group. HbA1c percentages were also normalized (5.45±0.2, P<.001) as compared to group 2. BMI values were also improved (P=0.01) after treatment. Combined supplementation of vitamin C and chromium reduce the plasma lipid percentage, blood glucose levels and also improve the ALT and AST functions.


Asunto(s)
Ácido Ascórbico , Índice de Masa Corporal , Cromo , Diabetes Mellitus Tipo 2 , Hemoglobina Glucada , Humanos , Femenino , Masculino , Ácido Ascórbico/uso terapéutico , Cromo/uso terapéutico , Adulto , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hemoglobina Glucada/metabolismo , Hiperglucemia/tratamiento farmacológico , Hiperglucemia/sangre , Hiperlipidemias/tratamiento farmacológico , Hiperlipidemias/sangre , Lípidos/sangre , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Persona de Mediana Edad
2.
Pak J Pharm Sci ; 37(1(Special)): 231-234, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38747274

RESUMEN

Increased levels of bad cholesterol in the body result in increasing blood pressure and weight gain. The rate of mortality in people, especially who are obese, is increasing due to absence of organic sources of fiber in their diets. Chia and fennel seeds are rich sources of fiber. The objective of this study was to evaluate the combined effect of Salvia hispanica (Chia seeds) and Foeniculum vulgare (Fennel seeds) against weight-loss and lipid profile in obese human subjects. The research was conducted on obese people aged 25 to 40 years at the Jinnah Hospital Lahore. The study design was randomized control trial (RCT). The sample size was calculated and was divided in-to two groups. With the duration of study being 3 months, pre-testing of all the participants was done. Group 1 was control group, given placebo treatment and Group 2 was an intervention group and given chia and fennel seeds. Post-testing was done and data were analyzed. Results showed that chia and fennel seeds have significant effect (p <0.05) on BMI and lipid profile hence, both are beneficial for lowering body weight and improving LDL, HDL, serum triglycerides and total cholesterol levels.


Asunto(s)
Foeniculum , Obesidad , Salvia , Semillas , Pérdida de Peso , Humanos , Foeniculum/química , Adulto , Obesidad/sangre , Obesidad/tratamiento farmacológico , Semillas/química , Salvia/química , Femenino , Masculino , Pérdida de Peso/efectos de los fármacos , Lípidos/sangre , Extractos Vegetales/farmacología , Fármacos Antiobesidad/farmacología , Fármacos Antiobesidad/uso terapéutico , Índice de Masa Corporal , Fitoterapia
3.
Biol Trace Elem Res ; 2024 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-38351346

RESUMEN

Diabetes is a serious metabolic disorder characterized by abnormal glucose levels in the body. Delayed wound healing is a severe diabetes complication. Nanotechnology represents the latest advancement in treating diabetic wounds through nanoparticles (NPs). In this study, silver nanoparticles (AgNPs) were synthesized using a green method involving cucumber pulp extract. The synthesis was confirmed using techniques including ultraviolet-visible spectrophotometry (UV-Vis), Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy dispersive X-ray (EDX). To evaluate wound-healing properties, mouse models were utilized with wounds induced by excision on the dorsal surface. An ointment containing silver nanoparticles was applied to assess its healing potential. Additionally, antibacterial and antioxidant activities were examined using agar well diffusion and DPPH scavenging methods, respectively. The results demonstrated that the ointment prepared with green synthesized AgNPs effectively healed the wounds within 15 days, while also exhibiting antibacterial and antioxidant properties. Therefore, it can be concluded that due to its efficacy in biological activities, silver nanoparticles can be employed in the treatment of diabetic wounds.

4.
Pak J Pharm Sci ; 36(5(Special)): 1591-1595, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38008957

RESUMEN

We investigate the synergistic effect of Moringa oleifera and Allium sativum on hyperlipidemic patients. It was a randomized controlled trial. The sample size of this study was 60 patients who were divided into four equal groups (n=15) through a random sampling technique. Pre assessment of all participants was conducted at the start of the research. The control group (group A) received atorvastatin 10mg QD as well as placebo capsules. The treatment group 1 (group B) received atorvastatin 10mg QD as well as Moringa oleifera 2g (capsule 1g BID). Treatment group 2 (group C) received atorvastatin 10mg QD as well as Allium sativum 2g (capsule 1g BID). Lastly, treatment group 3 (Group D) received atorvastatin 10mg QD as well as combined Moringa oleifera 2g (capsule 1g BID) and Allium sativum 2g (capsule 1g BID). After an intervention of 45 days, post assessment was conducted. The results showed total cholesterol and triglycerides and low-density lipoprotein of participants of treatment group 3 who received both MO and AS were statistically significant (p<0.05). The group that was on Moringa oleifera supplements alone was found to be statistically significant (p<0.05). This study concluded that Moringa oleifera and Allium sativum considerably improved the BMI and lipid profile of participants.


Asunto(s)
Ajo , Moringa oleifera , Humanos , Extractos Vegetales/uso terapéutico , Atorvastatina , Índice de Masa Corporal , Hojas de la Planta
5.
Pak J Pharm Sci ; 36(6(Special)): 1901-1908, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38264896

RESUMEN

Vitamin D supports the immune system fight TB by inhibiting Interferon-gamma (IFN-γ) and lowering host inflammation. The purpose of the research was to see if giving the vitamin D supplements to TB patients affected their prognosis. A randomized placebo control study of 200 TB patients was performed among which 106 received 400,000 IU of injectable vitamin D3 and 94 received placebo for 2 doses. Assessment was carried out at the end of every month for 3 months. IFN-γ responses to whole blood stimulation generated by the Mycobacterium tuberculosis sonicate (MTBs) antigen and early secreted and T cell activated 6 kDa (ESAT6) were assessed at 0 and 12 weeks. The statistical analysis used descriptive statistics (mean and standard deviation), Friedman's test and Fisher's test. The vitamin D group gained significantly more weight (+3.90 pounds) and had less persistent lung disease on imaging (1.33 zones vs. 1.84 zones). They also had a 50% decrease in cavity size. Additionally, patients with low baseline serum concentrations of 25-(OH)D had a significant increase in MTB-induced IFN-γ production after taking vitamin D supplements. Vitamin D administration in large amounts can hasten the recovery of TB patients. The findings point is a therapeutically useful activity of Vitamin D's in the management for tuberculosis.


Asunto(s)
Mycobacterium tuberculosis , Tuberculosis , Humanos , Vitaminas , Vitamina D , Suplementos Dietéticos , Interferón gamma
6.
Pak J Pharm Sci ; 32(2 (Supplementary)): 779-784, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31103972

RESUMEN

Prevalence of pulmonary tuberculosis (TB) in Pakistan is due to poor living conditions, malnutrition and low immunity. The present project was conducted to show the role of selenium complement to enhance the immune status against TB. Total of 80 human TB patients were divided into treatment (selenium and anti-tuberculosis drug) and control groups (anti-tuberculosis drug). Levels of selenium, immunoglobulin and leukocyte count were determined before and after treatment. Selenium showed significant increase in levels of immunoglobulin and leukocyte count in patients as compared to control group. The level of SOD, catalase, glutathione and total antioxidants were remarkably lowered among control type group as compared to treatment type group (P<0.01). However, the values of lipid peroxidation products malondialdehyde (MDA) were notably higher in control group than treatment group.


Asunto(s)
Antioxidantes/uso terapéutico , Antituberculosos/uso terapéutico , Factores Inmunológicos/uso terapéutico , Selenio/uso terapéutico , Tuberculosis Pulmonar/tratamiento farmacológico , Adulto , Antioxidantes/metabolismo , Catalasa/sangre , Suplementos Dietéticos , Femenino , Glutatión/sangre , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Recuento de Leucocitos , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Selenio/sangre , Superóxido Dismutasa/sangre , Resultado del Tratamiento , Tuberculosis Pulmonar/inmunología , Tuberculosis Pulmonar/microbiología
7.
Pak J Pharm Sci ; 32(1(Supplementary)): 269-276, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30829203

RESUMEN

Tuberculosis is one of the leading causes of mortality in Pakistan which is linked with malnutrition and weak immunity. Such people are more prone to chronic infections including TB. The current study aimed to assess the effect of supplementation of Vitamin E on the immune status of human subjects against pulmonary tuberculosis. A total of 80 patients with pulmonary TB were divided into treatment group (vitamin E) and control group (Anti-tuberculosis regime). Presence of acid fast bacilli in sputum sample, Erythrocyte sedimentation rate, total leucocytes counts, body mass index and mid arm muscle circumference (MAMC) were recorded as per standard protocol. Levels of vitamin E, IgG, IgM and T-Cell count were determined before and after treatment. The results showed that 16% males and 33% females were underweight who consumed 1145 kcal energy instead of 2270 kcal per day and 19.5 gram protein instead of 78.6 grams. A non significant effect of vitamin E on ESR and TLC values was observed but significant increase in level of immunoglobulins (IgG, IgM) and T-cell types (CD4+ and CD8+) was observed in patients as compared to control group. Results indicate that vitamin E plays important role in enhancing immunity of patients against TB.


Asunto(s)
Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/inmunología , Vitamina E/farmacología , Adulto , Antituberculosos/uso terapéutico , Dieta , Método Doble Ciego , Femenino , Humanos , Inmunoglobulina M/sangre , Recuento de Leucocitos , Masculino , Delgadez , Vitamina E/sangre , Vitamina E/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA